[artículo]
| Título : |
Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder : a randomized, multicenter, double blind, placebo controlled, proof of concept study |
| Tipo de documento: |
texto impreso |
| Autores: |
Joseph R. Calabrese, Autor ; Terence A. Ketter, Autor ; James M. Youakim, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 1363-1370 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antidepresivos, Benzodiazepinas, Trastorno bipolar, Trastorno depresivo mayor, Resistencia a los medicamentos, Farmacoterapia, Acido valproico. |
| Resumen: |
To evaluate the efficacy and safety of armodafinil, the longer-lasting isomer of modafinil, when used adjunctively in patients with bipolar depression.
In this 8-week, multicenter, randomized, double-blind, placebo-controlled study conducted between June 2007 and December 2008, patients who were experiencing a major depressive episode associated with bipolar I disorder (according to DSM-IV-TR criteria) despite treatment with lithium, olanzapine, or valproic acid were randomly assigned to adjunctive armodafinil 150 mg/d (n = 128) or placebo (n = 129) administered once daily in the morning. |
| Link: |
./index.php?lvl=notice_display&id=28248 |
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1363-1370
[artículo] Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder : a randomized, multicenter, double blind, placebo controlled, proof of concept study [texto impreso] / Joseph R. Calabrese, Autor ; Terence A. Ketter, Autor ; James M. Youakim, Autor . - 2022 . - pp. 1363-1370. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 10 (Octubre) . - pp. 1363-1370
| Palabras clave: |
Antidepresivos, Benzodiazepinas, Trastorno bipolar, Trastorno depresivo mayor, Resistencia a los medicamentos, Farmacoterapia, Acido valproico. |
| Resumen: |
To evaluate the efficacy and safety of armodafinil, the longer-lasting isomer of modafinil, when used adjunctively in patients with bipolar depression.
In this 8-week, multicenter, randomized, double-blind, placebo-controlled study conducted between June 2007 and December 2008, patients who were experiencing a major depressive episode associated with bipolar I disorder (according to DSM-IV-TR criteria) despite treatment with lithium, olanzapine, or valproic acid were randomly assigned to adjunctive armodafinil 150 mg/d (n = 128) or placebo (n = 129) administered once daily in the morning. |
| Link: |
./index.php?lvl=notice_display&id=28248 |
|
Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 10 (Octubre)
